Journal of the American Society of Nephrology 2014-04-01

Fabry disease: dose matters.

David G Warnock, Michael Mauer

Index: J. Am. Soc. Nephrol. 25(4) , 653-5, (2014)

Full Text: HTML

Abstract

Related Compounds

  • α-galactosidase

Related Articles:

High throughput screening for inhibitors of alpha-galactosidase.

2010-01-01

[Curr. Chem. Genomics 4 , 67-73, (2011)]

Endothelial nitric oxide synthase uncoupling and microvascular dysfunction in the mesentery of mice deficient in α-galactosidase A.

2014-01-01

[Am. J. Physiol. Gastrointest. Liver Physiol. 306(2) , G140-6, (2014)]

Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome.

2012-01-01

[PLoS ONE 7(10) , e47805, (2012)]

Cicer α-galactosidase immobilization onto functionalized graphene nanosheets using response surface method and its applications.

2014-01-01

[Food Chem. 142 , 430-8, (2014)]

Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.

2014-02-01

[J. Pak. Med. Assoc. 64(2) , 189-94, (2014)]

More Articles...